Her research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. She is currently the principle investigator of two NIH grants at the University of Michigan and completed a Fellowship in Endocrinology, Metabolism and Diabetes at the NIG, where she also chose to stay as a Senior Fellow, under the mentorship. The training at the NIG instilled a passion for rare diseases and how these “gifts of nature” empower the clinical investigators to unlock keys for novel disease mechanisms. It is through this experience that she realized that asking why something unusual happens in a patient may lead to an unexpected answer.